Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(10%)
Results Posted
0%(0 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Terminated(2)

Detailed Status

Completed7
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (10.0%)
N/A9 (90.0%)

Trials by Status

completed770%
recruiting110%
terminated220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10